Refreshing results…
Co-clinical Trial of Novel Bispecific Anti-HER2 Antibody Zanidatamab in Patient-Derived Xenografts
UploadActionability classification of variants of unknown significance correlates with functional effect
Download from doi.orgAdavosertib Enhances Antitumor Activity of Trastuzumab Deruxtecan in HER2-Expressing Cancers
UploadCamonsertib in DNA damage response-deficient advanced solid tumors: phase 1 trial results
UploadComutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC
UploadMissing publications? Search for publications with a matching author name.